The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2023(SUPPLEMENT) The Foundational Data Initiative
Study Rationale: This project aims to produce foundational data that will provide a resource for understanding the molecular basis of Parkinson’s disease (PD). The work, conducted in cells collected...
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023Characterization of a Novel Strategy to Target LRRK2 and Its Downstream Signaling Pathway
Study Rationale: Genetic mutations that activate LRRK2 are linked to familial Parkinson’s disease (PD). However, no clinically approved inhibitors for LRRK2 currently exist. In this study, we will...
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023Examining a Novel GCase Activator in Neurons Derived from People with Parkinson’s Disease
Study Rationale: Decreased function of the lysosomal enzyme GCase is associated with Parkinson’s disease (PD). We discovered that LIMP-2, the protein that transports GCase to the lysosome, also...
-
Research Grant, 2023(SUPPLEMENT) Development of an Imaging Tracer for Measuring Alpha-synuclein
Study Rationale: The discovery of new treatments for Parkinson’s disease (PD) has been hampered by the amount of time it can take (typically a number of years) to determine whether a drug works in a...
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023Structure and Mechanism of PINK1-TOM Supercomplex Formation
Study Rationale: Mitochondrial dysfunction plays an important role in the development and progression of Parkinson’s disease (PD). In healthy cells, when mitochondria become damaged, protein called...
-
Data-Driven Subtyping and Stratification Program, 2023Longitudinal Investigation of Statistical Subtype Analysis in Genetic Forms of Parkinson’s Disease
Study Rationale: People with Parkinson’s disease (PD) experience different symptoms and disease course, even individuals with the same genetic form of PD. Because we do not yet understand the range of...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.